Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus that is the causative
infectious agent of adult T-cell leukemia/lymphoma (ATL), an aggressive and fatal CD4+ T …

The human T‐cell lymphotropic virus type‐1 (HTLV‐1) is associated with severe
pathologies, such as HTLV‐1‐associated myelopathy/tropical spastic paraparesis …

Human T-cell leukemia virus type 1 (HTLV-1) is a complex human delta retrovirus that
infects an estimated 10–20 million people worldwide (Gessain and Cassar 2012). HTLV-1 …

HTLV-1 was discovered in the 1980s as the causative agent of adult T-cell leukemia and
HTLV-1-associated myelopathy/tropical spastic paraparesis. However, the precise …

The main mechanisms of interaction between Human T‐lymphotropic virus type 1 (HTLV‐1)
and its hosts in the manifestation of the related disease including HTLV‐1 associated …

Background In HTLV-1-associated malignant disease, adult T-cell leukaemia/lymphoma
(ATLL), the interaction of virus and host was evaluated at the chemokines gene expression …

Human T‐cell leukemia virus type 1 (HTLV‐1) is a replication‐competent human retrovirus
associated with two distinct types of disease only in a minority of infected individuals: the …

Human T cell leukemia virus type 1 (HTLV-1) is the etiologic agent of Adult T cell Leukemia
(ATL) and the neurological disorder HTLV-1-associated myelopathy/tropical spastic …

HTLV-1, the first human oncogenic retrovirus, is a type C retrovirus that belongs to the
Deltaretrovirus genus. The HTLV-1 genome has 8.5 kbp length, and consists of major genes …

Five to ten million individuals are infected by Human T-cell Leukemia Virus type 1 (HTLV-1).
HTLV-1 is transmitted through prolonged breast-feeding, by sexual contacts and by …